← Leaderboards
Ingegerd E. Hellstrom
Fred Hutchinson Cancer Research Center
$2,606,811
Attributed
$2,606,811
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $544.9K · FY2008–11$1M$750K$500K$250K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$2,606,811 · 3
By mechanism
R01$2,606,811 · 2
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Charles Drescher$9,013,816
- Nicole D. Urban$6,041,880
- Christopher I Li$36,171,442
- David G Maloney$3,575,748
- David M Koelle$18,912,642
Others in their field
Top investigators on “Ovary Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Joellen M. Schildkraut · Duke University$27,683,438
- Robert C Bast · University Of Texas Md Anderson Can Ctr$24,816,706
Research focus
Ovary NeoplasmsNeoplasm /Cancer VaccineEnzyme Linked Immunosorbent AssayTumor AntigensVector VaccineClinical ResearchVaccine DevelopmentCytotoxic T LymphocyteLaboratory MouseNeoplasm /Cancer ImmunotherapyHuman SubjectEarly DiagnosisBiomarkerTissue /Cell CultureTransfectionBiological Signal TransductionPolymerase Chain ReactionHuman TissueGrowth Factor ReceptorsCytokineCancer PreventionChemopreventionAntigen Antibody ReactionDrug Screening /Evaluation
Grant awards (16)
Mesothelin as biomarker and therapeutic target$261,900
R01 · FY2011 · CA · contact PI
Mesothelin as biomarker and therapeutic target$270,000
R01 · FY2010 · CA · contact PI
Mesothelin as biomarker and therapeutic target$274,911
R01 · FY2009 · CA · contact PI
Mesothelin as biomarker and therapeutic target$270,000
R01 · FY2009 · CA · contact PI
Mesothelin as biomarker and therapeutic target$270,000
R01 · FY2008 · CA · contact PI
MESOTHELIN ANTIGENS FOR DIAGNOSIS/THERAPY OF OVARIAN CA$315,000
R01 · FY2003 · CA
MESOTHELIN ANTIGENS FOR DIAGNOSIS/THERAPY OF OVARIAN CA$315,000
R01 · FY2002 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2002 · CA
MESOTHELIN ANTIGENS FOR DIAGNOSIS/THERAPY OF OVARIAN CA$315,000
R01 · FY2001 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2001 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2001 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2001 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2001 · CA
MESOTHELIN ANTIGENS FOR DIAGNOSIS/THERAPY OF OVARIAN CA$315,000
R01 · FY2000 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2000 · CA
NUCLEIC ACID VACCINES FOR CHEMOPREVENTON OF OVARIAN CANCER$0
P50 · FY2000 · CA